Security Snapshot

Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) Institutional Ownership

CUSIP: 45782T105

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

73

Shares (Excl. Options)

5,083,640

Price

$1.56

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
INMB on Nasdaq
Shares outstanding
27,969,231
Price per share
$1.13
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,083,640
Total reported value
$7,930,834
% of total 13F portfolios
0%
Share change
+454,027
Value change
+$653,755
Number of holders
73
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 45782T105.
  • 73 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 73 to 5 between Q4 2025 and Q1 2026.
  • Reported value moved from $7,930,834 to $13,427.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 73 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 5.2% $3,359,664 1,454,400 Highbridge Capital Management, LLC 30 Jun 2025
CVI Investments, Inc. 4.9% -10% $3,225,404 -$239,596 1,396,279 -6.9% CVI Investments, Inc. 30 Jun 2025
Praetorian PR LLC 3.4% -54% $2,127,972 -$1,700,160 921,200 -44% Kupperman Harris 30 Jun 2025

As of 31 Dec 2025, 73 institutional investors reported holding 5,083,640 shares of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB). This represents 18% of the company’s total 27,969,231 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 4.3% 1,212,100 +2.1% 0% $1,890,877
VANGUARD GROUP INC 3.4% 957,846 +9.3% 0% $1,494,240
GEODE CAPITAL MANAGEMENT, LLC 1.6% 441,650 -5.9% 0% $689,170
STATE STREET CORP 1.2% 347,259 +22% 0% $541,724
Dauntless Investment Group, LLC 1.1% 304,922 1.9% $475,678
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.9% 250,910 +60% 0% $391,419
RAYMOND JAMES FINANCIAL INC 0.75% 210,678 -22% 0% $328,658
NORTHERN TRUST CORP 0.63% 175,649 -7.1% 0% $274,012
MORGAN STANLEY 0.44% 122,512 +62% 0% $191,120
Westside Investment Management, Inc. 0.39% 108,950 +5.3% 0.03% $169,962
XTX Topco Ltd 0.25% 68,865 +41% 0% $107,429
UBS Group AG 0.22% 60,803 -61% 0% $94,852
Bank of New York Mellon Corp 0.21% 58,521 -2.2% 0% $91,293
GOLDMAN SACHS GROUP INC 0.2% 56,477 +269% 0% $88,104
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.18% 50,252 +20% 0% $78,393
Laird Norton Wetherby Trust Company, LLC 0.16% 45,000 +80% 0% $70,200
Jain Global LLC 0.15% 42,051 0% $65,600
JPMORGAN CHASE & CO 0.15% 41,365 -28% 0% $64,530
Focus Partners Advisor Solutions, LLC 0.15% 41,097 +0.36% 0% $64,111
PNC Financial Services Group, Inc. 0.14% 37,805 -1.5% 0% $58,976
BARCLAYS PLC 0.11% 32,018 +6.7% 0% $49,949
RHUMBLINE ADVISERS 0.1% 27,527 +22% 0% $42,935
BANK OF MONTREAL /CAN/ 0.09% 25,987 0% $40,540
TWO SIGMA SECURITIES, LLC 0.09% 25,363 0.01% $39,566
WELLS FARGO & COMPANY/MN 0.09% 24,857 +79% 0% $38,777

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 11,877 $13,427 +$1,702 $1.13 5
2025 Q4 5,083,640 $7,930,834 +$653,755 $1.56 73
2025 Q3 4,655,922 $9,636,676 -$1,934,721 $2.07 73
2025 Q2 5,623,690 $12,725,267 -$10,010,248 $2.31 78
2025 Q1 6,162,475 $48,114,521 -$163,536 $7.81 81
2024 Q4 6,324,914 $29,538,643 +$2,163,001 $4.67 72
2024 Q3 5,352,153 $28,834,750 +$6,030,346 $5.39 65
2024 Q2 4,566,933 $40,279,815 +$15,412,868 $8.82 56
2024 Q1 2,738,821 $32,179,382 +$5,308,168 $11.75 50
2023 Q4 2,292,004 $25,807,938 +$1,854,241 $11.26 47
2023 Q3 2,133,529 $14,477,326 -$5,887,298 $6.77 36
2023 Q2 2,186,070 $24,850,986 +$8,529,775 $9.08 32
2023 Q1 1,804,387 $11,657,371 +$1,101,433 $6.46 33
2022 Q4 1,645,407 $10,430,707 -$728,047 $6.34 32
2022 Q3 1,912,551 $11,855,780 -$744,186 $6.20 32
2022 Q2 2,010,894 $17,633,536 -$2,412,787 $8.84 34
2022 Q1 2,294,234 $19,315,368 -$2,106,118 $8.42 32
2021 Q4 2,484,556 $25,343,080 +$4,757,601 $10.20 42
2021 Q3 1,942,445 $37,703,608 +$4,889,864 $19.42 40
2021 Q2 1,710,752 $30,053,028 +$8,038,213 $17.57 39
2021 Q1 1,305,763 $15,492,692 +$5,444,483 $11.88 32
2020 Q4 793,136 $13,655,776 +$1,189,170 $17.21 25
2020 Q3 992,741 $10,252,248 +$6,463,618 $10.30 27
2020 Q2 358,561 $1,881,000 +$104,639 $5.17 11
2020 Q1 342,213 $1,139,000 +$200,616 $3.32 9
2019 Q4 282,367 $1,637,000 +$40,401 $5.80 9
2019 Q3 274,538 $1,620,000 +$1,390,869 $5.90 9
2019 Q2 38,466 $373,000 -$43,981 $9.72 7
2019 Q1 45,117 $352,000 +$352,000 $7.44 5

Sponsored